Evidence map›Paper›PMID 31118587›Full record

ArticlePatient preference and adherence2019

Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments.

Tetsuhiro Chiba, Atsushi Hiraoka, Shigeru Mikami, Masami Shinozaki, Yukio Osaki, Masamichi Obu, Takamasa Ohki, Naoyuki Mita, Dianne Ledesma, Nariaki Yoshihara and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Patient preference and adherence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Tetsuhiro ChibaDepartment of Gastroenterology and Nephrology, Chiba University Graduate School of Medicine, Chiba, Japan.
Atsushi HiraokaGastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Ehime Prefecture, Japan.
Shigeru MikamiDepartment of Internal Medicine, Kikkoman General Hospital, Noda-shi, Chiba Prefecture, Japan.
Masami ShinozakiDepartment of Gastroenterology, Numazu City Hospital, Shizuoka, Japan.
Yukio OsakiDepartment of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
Masamichi ObuDepartment of Gastroenterology, Kimitsu Chuo Hospital, Kisarazu City, Chiba Prefecture, Japan.
Takamasa OhkiDepartment of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan.
Naoyuki MitaMarket Access, Bayer Yakuhin, Ltd., Tokyo, Japan.
Dianne LedesmaMarket Access, Bayer Yakuhin, Ltd., Tokyo, Japan.
Nariaki YoshiharaMarket Access, Bayer Yakuhin, Ltd., Tokyo, Japan.
Kathleen BeusterienORS Health, Washington DC, USA.
Kaitlan AmosORS Health, Washington DC, USA.
John Fp BridgesDepartment of Biomedical Informatics and Department of Surgery, The Ohio State University College of Medicine, Columbus, OH, USA.
Osamu YokosukaJapan Community Health care Organization Funabashi Central Hospital, Funabashi, Chiba Prefecture, Japan.
Bayer (Japan) · JPChiba University · JPEhime Prefectural Central Hospital · JPJapan Community Healthcare Organization · JPKikkoman (Japan) · JPMitsui Memorial Hospital · JPNumazu City Hospital · JPOsaka Red Cross Hospital · JPThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

best-worst scalinghepatocellular carcinomapatient preference

Identifiers

PMID31118587
PMCPMC6503324
OpenAlexW2943780807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.